NAVIGATION
 
> Home
> OPPI Vision
> OPPI Mission
> Office Bearers 
> Committees
> News and Events
> Address by Shri Ashok Kumar, Secretary, Dept. of Pharmceuticals at 42nd AGM
> OPPI Position on IPR
> Pharma Spectrum - Monthly News At A Glance
> Pharma Spectrum - Year at a glance 2008 
> OPPI Position on Biosimilars
> OPPI Position on Data Protection
> OPPI Anti - Counterfeiting Guidelines
> Patents
> Drug Policy & Pricing
> Regulatory
> Links
> India OTC Profile 2008
> Important Government Notifications
 

 

IFPMA Clinical
Trials Portal

IFPMA - Improving
Global Health


OPPI Guide to
Road Safety


OPPI IPR
Symposium Proceedings


OPPI IPR
Symposium Videos




About Us Members Publications Contact Us
 
  PUBLICATIONS
Back to List of Publications

Outsourcing Opportunities in Indian Pharmaceutical Industry
The Pharmaceutical Industry in India is increasingly being recognised as a reliable source of quality medicines at affordable prices and is emerging as a global powerhouse. Apart from drugs and pharmaceuticals, India also offers tremendous outsourcing opportunities in areas such as clinical trials, R&D, custom synthesis, technical services, etc. To highlight these opportunities OPPI undertook a project in collaboration with Monitor Group. Monitor Group which is founded by Harvard Professor Michael Porter and his colleagues has vast experience in healthcare and pharmaceutical industry. This research project has culminated into an exhaustive report, which is the outcome of extensive research conducted by Monitor and OPPI in India and overseas.

Price: (excluding Service Tax)
Local – Indian Rupees: 1075
International: U.S.$ 40

Order Form

 



            Copyright © 2008. Organisation of Pharmaceutical Producers of India. All Rights Reserved.  |   Disclaimer  |